Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
umbilical cord blood NK cells
BIOLOGICAL
2 trials
Sponsors
Sun Yat-sen University
Conditions
Neuroblastoma
Soft Tissue Sarcoma (STS)
Phase 1
Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.
Recruiting
NCT06631391
Sun Yat-sen University
Neuroblastoma
Start: 2024-11-01
End: 2029-11-30
Target: 30
Updated: 2025-02-20
Unknown Phase
Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study
Recruiting
NCT06848582
Sun Yat-sen University
Soft Tissue Sarcoma (STS)
Start: 2024-11-01
End: 2028-02-01
Target: 40
Updated: 2025-02-27
Related Papers
Umbilical cord blood natural killer cells improve anti-GD2 antibody efficacy in neuroblastoma: from mouse to human.
2026-05-30